tiprankstipranks
Trending News
More News >
Lifeist Wellness (TSE:LFST)
:LFST

Lifeist Wellness (LFST) AI Stock Analysis

Compare
243 Followers

Top Page

TS

Lifeist Wellness

(OTC:LFST)

44Neutral
Lifeist Wellness faces significant financial challenges with declining revenues and negative cash flows. While the company has no debt, which is a positive aspect, these financial struggles limit its sustainability. Recent corporate events like strategic brand relaunches provide a positive outlook and potential for growth. However, the technical analysis shows a mixed picture with some bullish signs overshadowed by high volatility. The valuation remains challenging due to ongoing losses and the absence of a dividend yield.

Lifeist Wellness (LFST) vs. S&P 500 (SPY)

Lifeist Wellness Business Overview & Revenue Model

Company DescriptionLifeist Wellness (LFST) is a company operating in the health and wellness sector, focusing on providing innovative solutions to enhance the quality of life for its customers. Lifeist Wellness offers a diverse range of products, including wellness technology, cannabis, nutraceuticals, and personalized health solutions. The company's mission is to leverage cutting-edge technologies and scientific advancements to promote holistic health and well-being.
How the Company Makes MoneyLifeist Wellness generates revenue through multiple streams. The company earns money by selling its diverse product line, which includes cannabis products, wellness technology devices, and nutraceuticals, directly to consumers through its e-commerce platforms. Additionally, Lifeist partners with various retail and distribution networks to expand its market reach. The company also explores strategic partnerships and collaborations to enhance its product offerings and tap into new markets, contributing to its revenue growth. Furthermore, Lifeist invests in research and development to innovate and introduce new products, which helps maintain a competitive edge and drive sales.

Lifeist Wellness Financial Statement Overview

Summary
Income Statement
Balance Sheet
Cash Flow
Breakdown
TTMDec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Income StatementTotal Revenue
15.58M21.66M22.07M22.82M25.10M16.34M
Gross Profit
3.51M5.34M3.79M1.68M1.46M1.36M
EBIT
-2.21M-12.25M-15.56M-22.93M-25.99M5.11M
EBITDA
-11.31M-12.77M-17.44M-20.25M-23.66M-25.39M
Net Income Common Stockholders
-11.55M-14.13M-15.44M-23.80M-26.25M-63.17M
Balance SheetCash, Cash Equivalents and Short-Term Investments
309.12K1.45M3.80M12.74M10.28M37.86M
Total Assets
720.77K13.40M20.67M37.96M39.23M67.72M
Total Debt
0.001.27M328.33K554.59K755.32K19.59K
Net Debt
-297.12K-188.13K-3.47M-12.18M-9.52M-37.84M
Total Liabilities
259.89K9.94M7.30M11.89M10.24M11.94M
Stockholders Equity
460.88K3.46M13.36M26.06M29.25M55.86M
Cash FlowFree Cash Flow
260.58K-2.79M-16.04M-18.64M-27.98M-40.39M
Operating Cash Flow
328.62K-2.46M-15.35M-18.28M-24.54M-37.89M
Investing Cash Flow
81.94K1.28K6.69M-229.57K-2.70M-6.17M
Financing Cash Flow
-779.53K83.82K-252.29K21.02M-284.24K3.78M

Lifeist Wellness Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price0.04
Price Trends
50DMA
0.04
Positive
100DMA
0.04
Negative
200DMA
0.07
Negative
Market Momentum
MACD
<0.01
Negative
RSI
52.19
Neutral
STOCH
86.67
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:LFST, the sentiment is Neutral. The current price of 0.04 is above the 20-day moving average (MA) of 0.04, above the 50-day MA of 0.04, and below the 200-day MA of 0.07, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 52.19 is Neutral, neither overbought nor oversold. The STOCH value of 86.67 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for TSE:LFST.

Lifeist Wellness Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
TSACB
55
Neutral
$325.46M25.514.78%16.39%-98.10%
53
Neutral
$298.80M-84.50%-16.27%
51
Neutral
$5.31B3.33-39.82%2.92%17.95%1.84%
50
Neutral
$18.96M-72.23%-20.19%-10.71%
44
Neutral
$1.52M-29.87%-49.31%75.59%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:LFST
Lifeist Wellness
0.04
-0.16
-79.90%
TSE:WEED
Canopy Growth
2.07
-9.79
-82.55%
TSE:ACB
Aurora Cannabis
6.54
-2.62
-28.60%
TSE:CWEB
Charlotte's Web Holdings
0.12
-0.16
-57.41%

Lifeist Wellness Corporate Events

Product-Related AnnouncementsBusiness Operations and Strategy
Lifeist Wellness Relaunches Mikra with New Digital Strategy and Product Line
Positive
Apr 24, 2025

Lifeist Wellness Inc. has relaunched its Mikra brand with a new e-commerce website, refreshed branding, and a digital strategy aimed at driving revenue growth. The relaunch includes the introduction of three new products and a reformulated best-seller, designed to support brain health, hydration, and emotional well-being. The company has partnered with a digital design firm to enhance its online presence, implementing features such as subscription-driven growth, smart email automation, and a data-driven paid media overhaul. This strategic move is expected to enhance customer engagement, increase sales, and position Lifeist for scalable growth in the wellness industry.

Spark’s Take on TSE:LFST Stock

According to Spark, TipRanks’ AI Analyst, TSE:LFST is a Underperform.

Lifeist Wellness faces significant financial hurdles with ongoing losses and declining revenue. Despite no debt, the company’s shrinking asset base and negative cash flows raise concerns. Technical indicators show a mixed picture with some bullish signals but overall bearish trend. Recent strategic initiatives provide a positive outlook, yet the challenging valuation and high volatility warrant caution.

To see Spark’s full report on TSE:LFST stock, click here.

Product-Related AnnouncementsBusiness Operations and Strategy
Lifeist Wellness Announces Strategic Overhaul and Expansion for Mikra
Positive
Apr 1, 2025

Lifeist Wellness Inc. is set to unveil a major brand refresh and product expansion for its subsidiary, Mikra Cellular Sciences Inc., emphasizing new collaborations and a focus on cognitive health. The strategic overhaul includes a complete brand refresh, optimization of Mikra’s business model, and expansion into the electrolyte category, positioning Mikra for sustainable growth and reinforcing its role as a high-growth asset within Lifeist’s portfolio. This transformation aims to enhance Mikra’s market position, optimize operations, and drive long-term revenue growth, with new products and collaborations set to launch in April 2025.

Business Operations and Strategy
Lifeist Wellness Unveils 2025 Strategic Initiatives for Growth and Innovation
Positive
Jan 30, 2025

Lifeist Wellness Inc. has announced its strategic initiatives for 2025, emphasizing growth and innovation in the wellness industry. The company plans to establish strategic partnerships, improve operational efficiencies, strengthen financial position, and expand its brand portfolio, particularly through its subsidiary, Mikra. These initiatives aim to enhance Lifeist’s market position and deliver transformative wellness products to meet the growing consumer demand for health and well-being.

Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.